Search Within

Michael Morris

Formats
  1. Meeting Abstract (273)
  2. Journal Article (266)
  3. Review (19)
  4. Book Section (6)
  5. Editorial (6)
  6. Correspondence (4)
  7. Guidelines (3)
  8. Miscellaneous (2)
  9. Conference Paper (1)
Groups
  1. Department of Medicine (580)
  2. Genitourinary Oncology Service (580)
  3. Solid Tumor Oncology Division (580)
  4. Radiology, Department of (163)
  5. GSK Faculty (161)
  6. Molecular Imaging and Therapy Service (140)

More Groups

People
  1. Howard Scher (217)
  2. Steven Larson (93)
  3. Susan Slovin (90)
  4. Dana Rathkopf (79)
  5. Daniel Danila (54)
  6. Glenn Heller (54)

More People

Years
  1. 2025 (21)
  2. 2024 (50)
  3. 2023 (40)
  4. 2022 (50)
  5. 2021 (42)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (238)
  2. Journal of Nuclear Medicine (43)
  3. Clinical Cancer Research (33)
  4. Annals of Oncology (30)
  5. Cancer (18)
  6. European Urology (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (248)
  2. American Association for Cancer Research (43)
  3. Society of Nuclear Medicine (43)
  4. Oxford University Press (41)
  5. Elsevier Science, Inc. (39)
  6. Elsevier Inc. (27)

More Publishers

Results (580)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Hormonal induction followed by rapid hormonal cycling for prostate cancer (PC): The MEN's Cycle
    Meeting Abstract

    Nordquist, L.; Sauter, N.; Morris, M.; Smaletz, O.; Konopelski, K.; Delacruz, A.; Heller, G.; Scher, H. I.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Phase I trial of exogenous testosterone (T) for the treatment of castrate metastatic prostate cancer (PC)
    Meeting Abstract

    Morris, M. J.; Kelly, W. K.; Slovin, S.; Sauter, N.; Eicher, C.; Regan, K.; Curley, T.; Delacruz, A.; Reuter, V.
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma - Reply
    Journal Article

    Altundag, K.; Altundag, O.; Morandi, P.; Gunduz, M.; Morris, M. J.; Scher, H. I.; Sauter, N.
    Cancer (2004)

    Fulltext@MSK | Save
  • Targeting osseous metastases: Rationale and development of radio-immunotherapy for prostate cancer
    Journal Article

    Morris, M. J.; Pandit-Taskar, N.; Divgi, C.; Larson, S.; Scher, H. I.
    Current Oncology Reports (2004)

    Fulltext@MSK | Save
  • Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: Recommendations from the Prostate-Specific Antigen Working Group
    Journal Article

    Scher, H. I.; Eisenberger, M.; D'Amico, A. V.; Halabi, S.; Small, E. J.; Morris, M.; Kattan, M. W.; Roach, M.; Kantoff, P.; Pienta, K. J.; more...
    Journal of Clinical Oncology (2004)

    Fulltext@MSK | Save
  • Tumor localization of 16β-(18)F-fluoro-5α- dihydrotestosterone versus (18)F-FDG in patients with progressive, metastatic prostate cancer
    Journal Article

    Larson, S. M.; Morris, M.; Guenther, I.; Beattie, B.; Humm, J. L.; Akhurst, T.; Finn, R. D.; Erdi, Y.; Pentlow, K.; Dyke, J.; more...
    Journal of Nuclear Medicine (2004)

    Fulltext@MSK | Save
  • High-dose calcitriol, zoledronate, and dexamethasone for the treatment of progressive prostate carcinoma
    Journal Article

    Morris, M. J.; Smaletz, O.; Solit, D.; Kelly, W. K.; Slovin, S.; Flombaum, C.; Curley, T.; Delacruz, A.; Schwartz, L.; Fleisher, M.; more...
    Cancer (2004)

    Fulltext@MSK | Save
  • PET-based radiation dosimetry in man of 18F- fluorodihydrotestosterone, a new radiotracer for imaging prostate cancer
    Journal Article

    Zanzonico, P. B.; Finn, R.; Pentlow, K. S.; Erdi, Y.; Beattie, B.; Akhurst, T.; Squire, O.; Morris, M.; Scher, H.; McCarthy, T.; more...
    Journal of Nuclear Medicine (2004)

    Fulltext@MSK | Save
  • Imaging therapeutic response in human bone marrow using rapid whole-body MRI
    Journal Article

    Ballon, D.; Watts, R.; Dyke, J. P.; Lis, E.; Morris, M. J.; Scher, H. I.; Uluǧ, A. M.; Jakubowski, A. A.
    Magnetic Resonance in Medicine (2004)

    Fulltext@MSK | Save
  • Phase I trial to evaluate J591 as a vascular targeting agent in patients with advanced solid tumors
    Meeting Abstract

    Morris, M. J.; Divgi, C.; Kelly, W. K.; Slovin, S.; Solit, D.; Shaffer, D.; Halpern, J.; Delacruz, A.; Curley, T.; Nacca, A.; more...
    Proceedings of the American Association for Cancer Research Annual Meeting (2003)

    Fulltext@MSK | Save